Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
569.9 ILa | -0.02% | +36.86% | +248.56% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 151.8 | 21.7 | 64.19 |
Enterprise Value (EV) 1 | 103.4 | 0.4154 | 26.25 |
P/E ratio | -3.56 x | -0.79 x | -3.48 x |
Yield | - | - | - |
Capitalization / Revenue | 10.7 x | 4.22 x | 12.1 x |
EV / Revenue | 7.28 x | 0.08 x | 4.96 x |
EV / EBITDA | -2.42 x | -0.02 x | -1.52 x |
EV / FCF | -6,026,538 x | -30,206 x | 15,037,949 x |
FCF Yield | -0% | -0% | 0% |
Price to Book | 2.17 x | 0.51 x | 2.51 x |
Nbr of stocks (in thousands) | 39,220 | 39,234 | 39,263 |
Reference price 2 | 3.871 | 0.5530 | 1.635 |
Announcement Date | 3/29/22 | 3/20/23 | 3/11/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 9.596 | 20.06 | 22.3 | 14.2 | 5.143 | 5.288 |
EBITDA 1 | 0.379 | 2.012 | -1.173 | -42.78 | -26.74 | -17.3 |
EBIT 1 | 0.136 | 1.746 | -1.475 | -43.32 | -27.38 | -17.89 |
Operating Margin | 1.42% | 8.71% | -6.61% | -305.13% | -532.34% | -338.26% |
Earnings before Tax (EBT) 1 | 1.955 | 3.181 | -0.457 | -40.33 | -27.46 | -18.39 |
Net income 1 | 1.853 | 2.696 | -0.007 | -41.57 | -27.56 | -18.33 |
Net margin | 19.31% | 13.44% | -0.03% | -292.79% | -535.91% | -346.61% |
EPS 2 | 0.0618 | 0.0899 | -0.000233 | -1.089 | -0.7022 | -0.4700 |
Free Cash Flow | - | 2.065 | -1.986 | -17.16 | -13.75 | 1.746 |
FCF margin | - | 10.3% | -8.9% | -120.86% | -267.36% | 33.01% |
FCF Conversion (EBITDA) | - | 102.62% | - | - | - | - |
FCF Conversion (Net income) | - | 76.59% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 1/19/21 | 1/19/21 | 3/29/21 | 3/29/22 | 3/20/23 | 3/11/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 7.36 | 12.3 | 9.87 | - | - | - |
Net Cash position 1 | - | - | - | 48.4 | 21.3 | 37.9 |
Leverage (Debt/EBITDA) | 19.41 x | 6.12 x | -8.413 x | - | - | - |
Free Cash Flow | - | 2.06 | -1.99 | -17.2 | -13.8 | 1.75 |
ROE (net income / shareholders' equity) | - | 75% | -0.15% | -112% | -48.9% | -53.8% |
ROA (Net income/ Total Assets) | - | 6.5% | -4.06% | -43.4% | -19.8% | -14.5% |
Assets 1 | - | 41.45 | 0.1723 | 95.72 | 138.9 | 126.3 |
Book Value Per Share 2 | 0.0900 | 0.1500 | 0.1500 | 1.780 | 1.090 | 0.6500 |
Cash Flow per Share 2 | 0.0200 | 0.0300 | 0.0700 | 0.7400 | 1.130 | 1.310 |
Capex 1 | 0.17 | 1.31 | 0.25 | 3.65 | 0.15 | 0.15 |
Capex / Sales | 1.77% | 6.55% | 1.14% | 25.69% | 2.86% | 2.76% |
Announcement Date | 1/19/21 | 1/19/21 | 3/29/21 | 3/29/22 | 3/20/23 | 3/11/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+248.56% | 60.29M | |
+13.84% | 3.41B | |
-27.22% | 1.76B | |
-48.93% | 895M | |
-21.75% | 638M | |
-13.89% | 337M | |
-35.24% | 275M | |
+15.54% | 239M | |
-7.71% | 219M | |
+10.63% | 146M |
- Stock Market
- Equities
- RZR Stock
- Financials Razor Labs